NCT06520670View on ClinicalTrials.gov

Urinary G3BP as a Novel Biomarker in Lupus Nephritis

Not yet recruitingOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Lupus Nephritis
Interventions
DIAGNOSTIC_TEST

Urinary galectin-3 binding protein

Investigate urinary galectin-3 binding protein (G3BP) as a biomarker for lupus nephritis and indicator for disease activity.

All Listed Sponsors
lead

Assiut University

OTHER

NCT06520670 - Urinary G3BP as a Novel Biomarker in Lupus Nephritis | Biotech Hunter | Biotech Hunter